Cofco Biochemical Valuation
| 000930 Stock | 6.09 0.17 2.87% |
At this time, the firm appears to be overvalued. Cofco Biochemical Anhui shows a prevailing Real Value of USD5.67 per share. The current price of the firm is USD6.09. Our model approximates the value of Cofco Biochemical Anhui from analyzing the firm fundamentals such as return on equity of -0.0227, and Profit Margin of (0.01) % as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.0777 | Enterprise Value 13.7 B | Enterprise Value Ebitda 25.0548 | Price Sales 0.5432 | Enterprise Value Revenue 0.6596 |
Overvalued
Today
Please note that Cofco Biochemical's price fluctuation is slightly risky at this time. Calculation of the real value of Cofco Biochemical Anhui is based on 3 months time horizon. Increasing Cofco Biochemical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cofco Biochemical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cofco Stock. However, Cofco Biochemical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.09 | Real 5.67 | Hype 5.93 | Naive 5.83 |
The real value of Cofco Stock, also known as its intrinsic value, is the underlying worth of Cofco Biochemical Anhui Company, which is reflected in its stock price. It is based on Cofco Biochemical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cofco Biochemical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cofco Biochemical Anhui helps investors to forecast how Cofco stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cofco Biochemical more accurately as focusing exclusively on Cofco Biochemical's fundamentals will not take into account other important factors: Cofco Biochemical Cash |
|
Cofco Biochemical Total Value Analysis
Cofco Biochemical Anhui is presently forecasted to have takeover price of 13.71 B with market capitalization of 11.29 B, debt of 3.22 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Cofco Biochemical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.71 B | 11.29 B | 3.22 B |
Cofco Biochemical Investor Information
About 58.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.08. In the past many companies with similar price-to-book ratios have beat the market. Cofco Biochemical Anhui has Price/Earnings To Growth (PEG) ratio of 1.65. The entity recorded a loss per share of 0.14. The firm last dividend was issued on the 3rd of July 2023. Cofco Biochemical had 2:1 split on the 7th of December 2005. Cofco Biochemical Anhui is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Cofco Biochemical Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Cofco suggests not a very effective usage of assets in December.Cofco Biochemical Ownership Allocation
Cofco Biochemical holds a total of 1.86 Billion outstanding shares. Cofco Biochemical Anhui retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cofco Biochemical Profitability Analysis
The company reported the revenue of 20.38 B. Net Loss for the year was (601.63 M) with profit before overhead, payroll, taxes, and interest of 2.08 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cofco Biochemical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cofco Biochemical and how it compares across the competition.
About Cofco Biochemical Valuation
The stock valuation mechanism determines Cofco Biochemical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cofco Biochemical. We calculate exposure to Cofco Biochemical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cofco Biochemical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.1 B | 1.8 B |
Complementary Tools for Cofco Stock analysis
When running Cofco Biochemical's price analysis, check to measure Cofco Biochemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cofco Biochemical is operating at the current time. Most of Cofco Biochemical's value examination focuses on studying past and present price action to predict the probability of Cofco Biochemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cofco Biochemical's price. Additionally, you may evaluate how the addition of Cofco Biochemical to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |